These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 12151872)

  • 1. Dissecting the role of chymase in angiotensin II formation and heart and blood vessel diseases.
    Dell'Italia LJ; Husain A
    Curr Opin Cardiol; 2002 Jul; 17(4):374-9. PubMed ID: 12151872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The chymase-angiotensin system in humans: biochemistry, molecular biology and potential role in cardiovascular diseases.
    Liao Y; Husain A
    Can J Cardiol; 1995 Aug; 11 Suppl F():13F-19F. PubMed ID: 7664213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Role of angiotensin II-forming enzymes, angiotensin-converting enzyme and chymase].
    Takai S; Miyazaki M
    Nihon Rinsho; 1999 May; 57(5):1078-83. PubMed ID: 10361438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [involvement of chymase in pathogenesis of cardiovascular diseases].
    Urata H
    Nihon Rinsho; 2004 Mar; 62 Suppl 3():147-51. PubMed ID: 15171359
    [No Abstract]   [Full Text] [Related]  

  • 5. The renin-angiotensin system and vascular function. The role of angiotensin II, angiotensin-converting enzyme, and alternative conversion of angiotensin I.
    Roks A; Buikema H; Pinto YM; van Gilst WH
    Heart Vessels; 1997; Suppl 12():119-24. PubMed ID: 9476561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chymase-dependent angiotensin II forming systems in humans.
    Urata H; Nishimura H; Ganten D
    Am J Hypertens; 1996 Mar; 9(3):277-84. PubMed ID: 8695029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue angiotensin II system in the human heart.
    Urata H; Hoffmann S; Ganten D
    Eur Heart J; 1994 Dec; 15 Suppl D():68-78. PubMed ID: 7713117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chymase: its pathophysiological roles and inhibitors.
    Fukami H; Okunishi H; Miyazaki M
    Curr Pharm Des; 1998 Dec; 4(6):439-53. PubMed ID: 10197055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of angiotensin II formation in humans.
    Urata H; Nishimura H; Ganten D
    Eur Heart J; 1995 Dec; 16 Suppl N():79-85. PubMed ID: 8682066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pathophysiological roles of human chymase].
    Nakayama S; Urata H; Arakawa K
    Nihon Rinsho; 1997 Aug; 55(8):1903-8. PubMed ID: 9284400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac angiotensin II formation: the angiotensin-I converting enzyme and human chymase.
    Urata H; Ganten D
    Eur Heart J; 1993 Nov; 14 Suppl I():177-82. PubMed ID: 8293772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes of chymase, angiotensin converting enzyme and angiotensin II type 1 receptor expressions in the hamster heart during the development of heart failure.
    Chen PM; Leng XG; Fan LL; Ma J; Wang YF; Chen LY
    Chin Med J (Engl); 2005 Nov; 118(22):1886-92. PubMed ID: 16313843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin-converting enzyme-independent pathways of angiotensin II formation in human tissues and cardiovascular diseases.
    Urata H; Nishimura H; Ganten D; Arakawa K
    Blood Press Suppl; 1996; 2():22-8. PubMed ID: 8913536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chymase: a new pharmacologic target in cardiovascular disease.
    Bacani C; Frishman WH
    Cardiol Rev; 2006; 14(4):187-93. PubMed ID: 16788331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new myocardial conversion of angiotensin I.
    Ferrario CM; Chappell MC
    Curr Opin Cardiol; 1994 Sep; 9(5):520-6. PubMed ID: 7987030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The functional ratio of chymase and angiotensin converting enzyme in angiotensin I-induced vascular contraction in monkeys, dogs and rats.
    Jin D; Takai S; Yamada M; Sakaguchi M; Miyazaki M
    Jpn J Pharmacol; 2000 Dec; 84(4):449-54. PubMed ID: 11202618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin-converting enzyme-independent angiotensin formation in a human model of myocardial ischemia: modulation of norepinephrine release by angiotensin type 1 and angiotensin type 2 receptors.
    Maruyama R; Hatta E; Yasuda K; Smith NC; Levi R
    J Pharmacol Exp Ther; 2000 Jul; 294(1):248-54. PubMed ID: 10871319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin I converting enzyme and chymase in cardiovascular tissues.
    Nishimura H; Hoffmann S; Baltatu O; Sugimura K; Ganten D; Urata H
    Kidney Int Suppl; 1996 Jun; 55():S18-23. PubMed ID: 8743505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time-dependent expression of chymase and angiotensin converting enzyme in the hamster heart under pressure overload.
    Li P; Chen PM; Wang SW; Chen LY
    Hypertens Res; 2002 Sep; 25(5):757-62. PubMed ID: 12452330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of chymase-dependent angiotensin II formation in regulating blood pressure in spontaneously hypertensive rats.
    Kirimura K; Takai S; Jin D; Muramatsu M; Kishi K; Yoshikawa K; Nakabayashi M; Mino Y; Miyazaki M
    Hypertens Res; 2005 May; 28(5):457-64. PubMed ID: 16156510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.